Balancing risks and benefits in the treatment of patients with Bacillus Calmette-Guerin-unresponsive high-risk non-muscle-invasive bladder cancer

被引:0
作者
Unsworth-White, Samantha [1 ]
Humayun-Zakaria, Nada [2 ,3 ]
Bryan, Richard T. [3 ]
机构
[1] Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol, England
[2] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, England
[3] Univ Birmingham, Bladder Canc Res Ctr, Birmingham B15 2TT, England
关键词
Atezolizumab; circulating-tumour DNA (ctDNA); non-muscle-invasive bladder cancer (NMIBC); Bacillus Calmette-Guerin-unresponsive (BCG-unresponsive); immuno-oncology; OPEN-LABEL; ATEZOLIZUMAB; MULTICENTER; BCG;
D O I
10.21037/tau-24-529
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [1] Use of atezolizumab in bacillus Calmette-Guérin-unresponsive high-risk non-muscle-invasive bladder cancer
    Akinsola, Olutiwa A.
    Talwar, Ruchika
    Baskin, Avi
    Luckenbaugh, Amy N.
    Awamlh, Bashir Al Hussein Al
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2024, 13 (06) : 1061 - 1063
  • [2] Emerging treatment options for bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer
    Kokorovic, Andrea
    Ory, Jesse
    Saad, Fred
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2022, 16 (01) : 48 - 53
  • [3] Role of immunotherapy in bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer
    Mukherjee, Neelam
    Svatek, Robert S.
    Mansour, Ahmed M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (03) : 103 - 108
  • [4] Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes
    Tan, Wei Shen
    Grajales, Valentina
    Contieri, Roberto
    Hensley, Patrick
    Bree, Kelly
    Msaouel, Pavlos
    Guo, Charles C.
    Nogueras-Gonzalez, Graciela M.
    Navai, Neema
    Dinney, Colin P.
    Kamat, Ashish M.
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 53 : 16 - 22
  • [5] Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy
    Iida, Kota
    Miyake, Makito
    Murakami, Kaoru
    Komiyama, Motokiyo
    Okajima, Eijiro
    Sazuka, Tomokazu
    Nishiyama, Naotaka
    Yasumoto, Hiroaki
    Kimura, Takahiro
    Ito, Akihiro
    Shiga, Kenichiro
    Yamagishi, Atsushi
    Kikuchi, Hiroshi
    Sugimoto, Mikio
    Taoka, Rikiya
    Kobayashi, Takashi
    Kojima, Takahiro
    Kitamura, Hiroshi
    Nishiyama, Hiroyuki
    Fujimoto, Kiyohide
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (11) : 2104 - 2112
  • [6] Bacillus Calmette-Guerin Without Maintenance Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer
    Herr, Harry W.
    Dalbagni, Guido
    Donat, Sherri M.
    EUROPEAN UROLOGY, 2011, 60 (01) : 32 - 36
  • [7] Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guerin for the Treatment of Patients With High-Risk Non-Muscle-Invasive Bladder Cancer
    McElree, Ian M.
    Steinberg, Ryan L.
    Mott, Sarah L.
    O'Donnell, Michael A.
    Packiam, Vignesh T.
    JAMA NETWORK OPEN, 2023, 6 (02)
  • [8] The Role of Bacillus Calmette-Guerin in the Treatment of Non-Muscle-Invasive Bladder Cancer
    Gontero, Paolo
    Bohle, Andreas
    Malmstrom, Per-Uno
    O'Donnell, Michael A.
    Oderda, Marco
    Sylvester, Richard
    Witjes, Fred
    EUROPEAN UROLOGY, 2010, 57 (03) : 410 - 429
  • [9] International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guerin-exposed High-risk Non-muscle-invasive Bladder Cancer
    Roumiguie, Mathieu
    Kamat, Ashish M.
    Bivalacqua, Trinity J.
    Lerner, Seth P.
    Kassouf, Wassim
    Bohle, Andreas
    Brausi, Maurizio
    Buckley, Roger
    Persad, Raj
    Colombel, Marc
    Lamm, Donald
    Palou-Redorta, Juan
    Soloway, Mark
    Brothers, Ken
    Steinberg, Gary
    Lotan, Yair
    Sylvester, Richard
    Witjes, J. Alfred
    Black, Peter C.
    EUROPEAN UROLOGY, 2022, 82 (01) : 34 - 46
  • [10] Theories behind Bacillus Calmette-Guerin failure in high-risk non-muscle-invasive bladder cancer and update on current management
    Maroof, Hanna
    Paramore, Louise
    Ali, Ahmed
    CANCER PATHOGENESIS AND THERAPY, 2024, 2 (02): : 74 - 80